Skip to main content
logo
ImpediMed Limited (ASX:IPD)
Australia flag Australia · Delayed Price · Currency is AUD
0.0190
-0.0020 (-9.52%)
Feb 5, 2026, 4:10 PM AEST

ImpediMed Revenue

In the fiscal year ending June 30, 2025, ImpediMed had annual revenue of 12.72M AUD with 23.31% growth. ImpediMed had revenue of 6.72M in the half year ending June 30, 2025, with 18.05% growth.

Revenue
12.72M
Revenue Growth
+23.31%
P/S Ratio
3.04
Revenue / Employee
165.25K
Employees
77
Market Cap
38.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202512.72M2.41M23.31%
Jun 30, 202410.32M-1.03M-9.04%
Jun 30, 202311.34M778.00K7.36%
Jun 30, 202210.57M2.16M25.65%
Jun 30, 20218.41M2.67M46.47%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Compumedics51.04M
Nova Eye Medical29.27M
CleanSpace Holdings19.76M
Micro-X13.05M
CurveBeam AI12.10M
Control Bionics6.14M
CONNEQT Health6.05M
Atomo Diagnostics3.79M
Revenue Rankings

ImpediMed News

More News